Multitarget tyrosine kinase inhibition: [and the winner is...].
Verweij
Jaap
J
de Jonge
Maja
M
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy*; D009536:Niacinamide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009841:Oligonucleotides; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D012107:Research Design
D000970:Antineoplastic Agents; D007211:Indoles; D009841:Oligonucleotides; D047428:Protein Kinase Inhibitors; D009536:Niacinamide; D011505:Protein-Tyrosine Kinases; C519562:imetelstat